All Stories

  1. Temporal Trends and Seasonality of Invasive Candidiasis During and After the COVID-19 Pandemic: An Interrupted Time Series Analysis in Colombia
  2. Directrices unificadas para la interpretación y manejo de las viremias de bajo nivel persistentes del VIH en Colombia. Declaración de consenso
  3. Establishing tropical medicine as a recognized medical specialty or strengthening its training within infectious diseases residency programs in Colombia: an urgent need
  4. Multi-fungicide resistance in both clinical and environmental isolates of the human fungal pathogen Aspergillus fumigatus
  5. Chest X‐Ray Interpretation in the EPICO Pediatric COVID‐19 Study: Addressing Misconceptions
  6. Renaming the tropical febrile syndrome: A clinical and semantic imperative in global health
  7. Correction: Long COVID clinical evaluation, research and impact on society: a global expert consensus
  8. Mpox: Characterization and clinical outcomes of patients in Colombian healthcare institutions
  9. Infectious diseases prevention and vaccination in migrants in Latin America: The challenges of transit through the treacherous Darien gap, Panama
  10. Key success factors in clinical trial operation of the smallpox vaccine LC16m8 against mpox in Colombia
  11. Corrigendum: Phenotypic Variation in Disease Severity Among Hospitalized Pediatric Patients With COVID-19: Assessing the Impact of COVID-19 in the EPICO Study
  12. Phenotypic Variation in Disease Severity Among Hospitalized Pediatric Patients With COVID-19: Assessing the Impact of COVID-19 in the EPICO Study
  13. Evidence-based clinical standard for the diagnosis and treatment of invasive lung aspergillosis in the patient with oncohematologic disease
  14. Multiplex PCR Pneumonia Panel in Critically Ill Patients Did Not Modify Mortality: A Cohort Study
  15. What to Look for in Chest X‐Rays of Pediatric Patients With COVID‐19: Insights From a Colombian Cohort
  16. Uveítis infecciosa: epidemiología, etiología, rendimiento de pruebas diagnósticas y tratamiento
  17. Evidence-based clinical standard for the diagnosis and treatment of candidemia in critically ill patients in the intensive care unit
  18. Management and efficiency in highly complex public healthcare: an analysis of financial ratios and non-parametric statistic
  19. Development of a diagnostic multivariable prediction model of a positive SARS-CoV-2 RT-PCR result in healthcare workers with suspected SARS-CoV-2 infection in hospital settings
  20. Interplay of Transcriptomic Regulation, Microbiota, and Signaling Pathways in Lung and Gut Inflammation-Induced Tumorigenesis
  21. Predictive modelling of the effectiveness of vaccines against COVID-19 in Bogotá: Methodological innovation involving different variants and computational optimisation efficiency
  22. ¿Cómo prepararnos para una futura pandemia?
  23. Global transcriptomic network analysis of the crosstalk between microbiota and cancer-related cells in the oral-gut-lung axis
  24. The Effectiveness of Generic Piperacillin/Tazobactam in Managing Gram-Negative Bacillary Bacteremia in Adult Patients at a Tertiary Care Hospital
  25. Guía de práctica clínica para el diagnóstico y tratamiento de la histoplasmosis en personas adultas que viven con el VIH – versión corta
  26. Efficacy of Continuous vs. Intermittent Administration of Cefepime in Adult ICU Patients with Gram-Negative Bacilli Bacteremia: A Randomized Double-Blind Clinical Study
  27. Financiación pública de los sistemas de Ciencia e Innovación en Latinoamérica: Una herramienta esencial para mejorar la prevención y la atención en salud
  28. Guía de práctica clínica para el diagnóstico y tratamiento de la criptococosis en personas adultas que viven con el VIH
  29. Differential Diagnosis in the Management of Acute Respiratory Infections through Point-of-Care Rapid Testing in a Post-Pandemic Scenario in Latin America: Special Focus on COVID-19, Influenza, and Respiratory Syncytial Virus
  30. Predictive models for health outcomes due to SARS-CoV-2, including the effect of vaccination: a systematic review
  31. Efficacy of Continuous vs. Intermittent Administration of Cefepime in Adult ICU Patients with Gram‐Negative Bacilli Bacteremia: A Randomized Double‐Blind Clinical Study
  32. Challenges and opportunities in the face of Mpox in Latin America
  33. Mpox: Characterization and Clinical Outcomes of Patients in Colombian Healthcare Institutions
  34. Mpox: Characterization and Clinical Outcomes of Patients in Colombian Healthcare Institutions
  35. Host Transcriptional Regulatory Genes and Microbiome Networks Crosstalk through Immune Receptors Establishing Normal and Tumor Multiomics Metafirm of the Oral-Gut-Lung Axis
  36. Impact of immunosuppression regimen on COVID-19 mortality in kidney transplant recipients: Analysis from a Colombian transplantation centers registry
  37. SARS-CoV-2 vaccination strategies: Should the extended dosing interval strategy be implemented in future pandemics?
  38. Multinational prospective cohort study of incidence and risk factors for central line-associated bloodstream infections in ICUs of 8 Latin American countries
  39. Bacteremia by non-O1/non-O139 Vibrio cholerae: Case description and literature review
  40. Long COVID in low-income and middle-income countries: the hidden public health crisis
  41. Reasons for antiretroviral switching in Colombia: A retrospective cohort study
  42. The global challenges of the long COVID-19 in adults and children
  43. Mortality Caused by Candida auris Bloodstream Infections in Comparison with Other Candida Species, a Multicentre Retrospective Cohort
  44. Interventions to Improve Antibiotic Use in Hospitals with Different Levels of Complexity in Colombia: Findings from a Before-and-After Study and Suggestions for the Future
  45. Associated factors for mortality in a COVID-19 colombian cohort: is the third wave relevant when Mu variant was predominant epidemiologically?
  46. Clinical and epidemiological characteristics of mpox: A descriptive cases series in Colombia
  47. Viral reactivations and co-infections in COVID-19 patients: a systematic review
  48. Guía de práctica clínica colombiana para el tratamiento de infecciones bacterianas de piel y tejidos blandos superficiales en Población pediátrica
  49. Consenso de expertos para el tratamiento antimicrobiano de las infecciones causadas por bacilos gram negativos multirresistentes en pacientes adultos
  50. Multinational prospective cohort study over 24 years of the risk factors for ventilator-associated pneumonia in 187 ICUs in 12 Latin American countries: Findings of INICC
  51. The Mortality Attributable to Candidemia in C. auris Is Higher than That in Other Candida Species: Myth or Reality?
  52. Fungemia in Hospitalized Adult Patients with Hematological Malignancies: Epidemiology and Risk Factors
  53. Comment on: Gaps and barriers in the implementation and functioning of antimicrobial stewardship programmes: results from an educational and behavioural mixed methods needs assessment in France, the United States, Mexico and India
  54. Molecular and Clinical Data of Antimicrobial Resistance in Microorganisms Producing Bacteremia in a Multicentric Cohort of Patients with Cancer in a Latin American Country
  55. Adenovirus Respiratory Infections Post Pandemic in Colombia
  56. Long COVID-19 in Latin America: Low prevalence, high resilience or low surveillance and difficulties accessing health care?
  57. Impact of immunosuppression regimen on COVID-19 mortality in kidney transplant recipients: Analysis from a Colombian transplantation centers registry
  58. Associated Factors for Mortality in a COVID-19 Colombian Cohort by Epidemic Wave: Is the Predominance of Mu Variant Relevant?
  59. Clinical and Epidemiological Characteristics of Mpox: A Descriptive Cases Series in Colombia
  60. Metformin Use Is Associated With Lower Mortality in Veterans With Diabetes Hospitalized With Pneumonia
  61. Expert review of global real-world data on COVID-19 vaccine booster effectiveness and safety during the omicron-dominant phase of the pandemic
  62. The Risk and Clinical Implications of Antibiotic-Associated Acute Kidney Injury: A Review of the Clinical Data for Agents with Signals from the Food and Drug Administration’s Adverse Event Reporting System (FAERS) Database
  63. Multinational Prospective Cohort Study of Mortality Risk Factors in 198 ICUs of 12 Latin American Countries over 24 Years: The Effects of Healthcare-Associated Infections
  64. Association of medical tests use with care continuity in primary care service: evidence from the Department of Veterans Affairs
  65. Expert Review of Global Real-World Data on COVID-19 Vaccine Booster Effectiveness & Safety During the Omicron-dominant Phase of the Pandemic
  66. Further implications on the global real-world vaccine effectiveness against SARS-CoV-2
  67. Section 2. Colombian consensus for prophylaxis, treatment and prevention of invasive aspergillosis in adult and pediatric patients
  68. Section 3. Colombian consensus on the diagnosis and treatment of extrapulmonary aspergillosis in adult patients
  69. Section 4. Colombian consensus on the diagnosis and treatment of chronic, saprophytic and/or allergic syndromes associated with Aspergillus spp. in adult and pediatric patients
  70. Section 1. Colombian consensus on the diagnosis and follow-up of invasive aspergillosis and Aspergillus disease in adult and pediatric patients
  71. Guía de práctica clínica para la Profilaxis quirúrgica antimicrobiana
  72. The environment also molds microbes in our respiratory airways that are important for our health
  73. Impact of SARS-CoV-2 vaccination in healthcare workers in a network of clinics in Latin America
  74. Cardiovascular risk factors and comorbidities in people living with HIV: A cross-sectional multicenter study from Colombia comorbidities in a Colombian PLWHIV population
  75. Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses
  76. An Operations Approach for Reducing Glycemic Variability: Evidence from a Primary Care Setting
  77. A simplified alternative diagnostic algorithm for SARS-CoV-2 suspected symptomatic patients and confirmed close contacts (asymptomatic): A consensus of Latin American experts
  78. Strengthening a Study of Diabetes Progression After Statin Use—Reply
  79. The Risk of Clostridioides difficile Recurrence after Initial Treatment with Vancomycin or Fidaxomicin Utilizing Cerner Health Facts
  80. Head-to-head comparison of CLSI, EUCAST, Etest and Vitek2 results for Candida auris susceptibility testing
  81. Impact of TR34/L98H, TR46/Y121F/T289A and TR53 Alterations in Azole-Resistant Aspergillus fumigatus on Sterol Composition and Modifications after In Vitro Exposure to Itraconazole and Voriconazole
  82. Effectiveness of rosuvastatin plus colchicine, emtricitabine/tenofovir and combinations thereof in hospitalized patients with COVID-19: a pragmatic, open-label randomized trial
  83. Associated Factors for Mortality in a COVID-19 Colombian Cohort by Epidemic Wave: Is the Predominance of Mu Variant Relevant?
  84. Genotypic, proteomic, and phenotypic approaches to decipher the response to caspofungin and calcineurin inhibitors in clinical isolates of echinocandin-resistantCandida glabrata
  85. Guía de práctica clínica para el manejo de la neumonía adquirida en la comunidad
  86. Long-term consequences of the misuse of ivermectin data
  87. Association of Statin Therapy Initiation With Diabetes Progression
  88. Enhancing Regulatory Decision Making for Postmarket Drug Safety
  89. Effectiveness of Beta-Lactam plus Doxycycline for Patients Hospitalized with Community-Acquired Pneumonia
  90. Colombian HIV/AIDS registry and health risk management
  91. Understanding the Potential Impact of Different Drug Properties on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Transmission and Disease Burden: A Modelling Analysis
  92. Effectiveness of Rosuvastatin plus Colchicine, Emtricitabine/Tenofovir and a combination of them in Hospitalized Patients with SARS Covid-19
  93. Understanding the Potential Impact of Different Drug Properties On SARS-CoV-2 Transmission and Disease Burden: A Modelling Analysis
  94. Manifestaciones radiológicas de la melioidosis pulmonar. Serie de casos
  95. SECCION I. Antecedentes de infección por SARS-CoV-2/COVID-19
  96. Clinical course, biomarkers, management and outcomes of patients hospitalised due to COVID-19 in Colombia
  97. Consensus Recommendations Based on Evidence for Abdominal Sepsis in the Pediatric and Adult Population of Colombia
  98. Implications of Antibiotic Use during the COVID-19 Pandemic: The Example of Associated Antimicrobial Resistance in Latin America
  99. Socioeconomic inequalities associated with mortality for COVID-19 in Colombia: a cohort nationwide study
  100. Association of Blood Pressure Variability and Diuretics With Cardiovascular Events in Patients With Chronic Kidney Disease Stages 1–5
  101. Guía de práctica clínica para la tamización de pacientes con riesgo de colonización por Enterobacterales productores de carbapenemasas y el manejo de infecciones causadas por estas bacterias
  102. Do the types and routes of proton pump inhibitor treatments affect clostridium difficile in ICU patients? A retrospective cohort study
  103. Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results
  104. Experience of clinical screening for COVID-19 among patients undergoing elective orthopedic surgeries: an alternative proposal
  105. Real-World Use of Generic Meropenem: Results of an Observational Study
  106. Prevalence and Significance of Potential Pharmacokinetic Drug–Drug Interactions Among Patients with Lung Cancer: Implications for Clinical Trials
  107. Burden and magnitude of risk in HIV/AIDS in the Colombian health system: a real-world data approach
  108. Socioeconomic inequalities associated with mortality for COVID-19 in Colombia: A cohort nation-wide study
  109. <p>Acetylcholine Regulates Pulmonary Pathology During Viral Infection and Recovery</p>
  110. Real-World Effectiveness of Meropenem: Results of an Observational Study in 84 Colombian Patients
  111. Citoquinas pro y anti-inflamatorias en la infección por SARS-CoV-2, en población de Colombia
  112. Case Report: Gestational Melioidosis through Perinatal Transmission
  113. A One Health Perspective to Recognize Fusarium as Important in Clinical Practice
  114. Candida auris: A Latent Threat to Critically Ill Patients With Coronavirus Disease 2019
  115. A One Health Perspective to Recognize Fusarium and Neocosmospora as Important in Clinical Practice
  116. Una hoja de ruta para la Vacuna COVID 19 en Colombia, un reto posible
  117. Maintaining Continuity in Service: An Empirical Examination of Primary Care Physicians
  118. Lactic acidosis incidence with metformin in patients with type 2 diabetes and chronic kidney disease: A retrospective nested case‐control study
  119. Correction to: Comparing Acute Kidney Injury Reports Among Antibiotics: A Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS)
  120. 1596-P: Evaluating Reports of Pancreatic Malignancy and Liraglutide: A Pharmacovigilance Study of the FDA Adverse Event Reporting System
  121. Toward to establish selection criteria for rapid serological tests for COVID-19
  122. Volver a empezar: cirugía electiva durante la pandemia del SARS-CoV2. Recomendaciones desde la Asociación Colombiana de Cirugía
  123. Testing Dilemmas: Post negative, positive SARS-CoV-2 RT-PCR – is it a reinfection?
  124. A new emerging zoonotic virus of concern: the 2019 novel Coronavirus (COVID-19)
  125. Consenso colombiano de atención, diagnóstico y manejo de la infección por SARS-COV-2/COVID 19 en establecimientos de atención de la salud. Recomendaciones basadas en consenso de expertos e informadas en la evidencia
  126. Temporal Factors Associated With Opioid Prescriptions for Patients With Pain Conditions in an Urban Emergency Department
  127. Rates of appropriate laxative prophylaxis for opioid-induced constipation in veterans with lung cancer: a retrospective cohort study
  128. Evaluation of Vitamin B12 Monitoring in Veterans With Type 2 Diabetes on Metformin Therapy
  129. Persistence of clonal azole-resistant isolates of Candida albicans from a patient with chronic mucocutaneous candidiasis in Colombia
  130. QTc Interval-Prolonging Medications Among Patients With Lung Cancer: Implications for Clinical Trial Eligibility and Clinical Care
  131. Impact of a Formulation Containing Unusual Polyunsaturated Fatty Acids, Trace Elements, Polyphenols and Plant Sterols on Insulin Resistance and Associated Disturbances
  132. Comparing Acute Kidney Injury Reports Among Antibiotics: A Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS)
  133. Association of atypical antipsychotics and mortality for patients hospitalised with pneumonia
  134. International Nosocomial Infection Control Consortium (INICC) report, data summary of 45 countries for 2012-2017: Device-associated module
  135. Risk factors associated with methicillin-resistant Staphylococcus aureus skin and soft tissue infections in hospitalized patients in Colombia
  136. Statin use and medically attended acute respiratory illness among influenza vaccine recipients
  137. Guía de práctica clínica para el diagnóstico y manejo de las infecciones de piel y tejidos blandos en Colombia
  138. Clinical practice guidelines: An Opportunity to provide health care with excellence and the new Colombian Guidelines for the diagnosis and management of Skin and Soft tissue infections (SSTIs)
  139. Case Series Study of Melioidosis, Colombia
  140. Risk of invasive fungal infections during hospital construction
  141. A cohort study of two intravenous treatments for iron deficiency in patients with heart failure
  142. Abstract 3368: Prevalence and significance of drug-drug interactions among patients with lung cancer
  143. Effect of carbapenem resistance on outcomes of bloodstream infection caused by Enterobacteriaceae in low-income and middle-income countries (PANORAMA): a multinational prospective cohort study
  144. Comparison between MALDI-TOF MS and MicroScan in the identification of emerging and multidrug resistant yeasts in a fourth-level hospital in Bogotá, Colombia
  145. The cost of hospital care for HIV patients in Colombia: an insurer’s perspective
  146. Melioidosis en Colombia, descripción de un caso clínico y consideraciones epidemiológicas
  147. First case of Aspergillus caelatus airway colonization in a Chronic Obstructive Pulmonary Disease patient
  148. Antifungal stewardship: consensus on the diagnosis, treatment, and prevention of Candida spp. disease is a fundamental step in the road map to achieve it
  149. Colombian consensus on the diagnosis, treatment, and prevention of Candida Spp. disease in children and adults*,+
  150. Fungicide-driven alterations in azole-resistant Aspergillus fumigatus are related to vegetable crops in Colombia, South America
  151. Evaluación y manejo del riesgo cardiovascular en infección por VIH. Consenso de expertos ACIN
  152. Paracoccidioidomycosis simulating Crohn’s disease
  153. Necrotizing fasciitis caused by Apophysomyces variabilis in an immunocompetent patient
  154. Association of Statin Use with Increased Risk of Musculoskeletal Conditions: A Retrospective Cohort Study
  155. Use of QTc-prolonging medications among patients with lung cancer: implications for clinical trials and standard clinical care.
  156. Impact of total body weight on acute kidney injury in patients with gram-negative bacteremia
  157. Opciones terapéuticas frente a especies de Candida resistentes a las equinocandinas
  158. Polypharmacy and patterns of prescription medication use among cancer survivors
  159. First report of sporadic cases of Candida auris in Colombia
  160. Burden of Fungal Infections in Colombia
  161. What has been researched about MDR- Candida auris ? A bibliometric analysis on the ‘new kid on the block’ in hospital-associated infections
  162. Erratum for Arias et al., “A Prospective Cohort Multicenter Study of Molecular Epidemiology and Phylogenomics of Staphylococcus aureus Bacteremia in Nine Latin American Countries”
  163. Association of Statin Therapy With Risk of Epilepsy in 2 Propensity Score–Matched Cohorts
  164. Diagnosis and treatment of latent tuberculosis in patients with multiple sclerosis, expert consensus. On behalf of the Colombian Association of Neurology, Committee of Multiple Sclerosis
  165. Usefulness of thick blood smears in the diagnosis of disseminated histoplasmosis
  166. Practical Recommendations for Preoperative Skin Antisepsis
  167. Staphylococcus aureus bloodstream infections in Latin America: results of a multinational prospective cohort study
  168. Metformin Safety Warnings and Diabetes Drug Prescribing Patterns for Older Nursing Home Residents
  169. A Prospective Cohort Multicenter Study of Molecular Epidemiology and Phylogenomics of Staphylococcus aureus Bacteremia in Nine Latin American Countries
  170. Association of Statin Use With Risk of Back Disorder Diagnoses
  171. Tigeciclina en infecciones de piel y tejidos blandos complicadas.
  172. First Colombian consensus on congenital Chagas and clinical approach for women of child-bearing age diagnosed with Chagas
  173. Tigeciclina en infecciones intraabdominales complicadas
  174. Safety of Tofacitinib in the Treatment of Rheumatoid Arthritis in Latin America Compared With the Rest of the World Population
  175. High Initiation of Adjuvant Hormonal Therapy Among Uninsured Stages I–III Breast Cancer Patients Treated in a Safety-Net Healthcare System
  176. Impact of total body weight on 30-day mortality in patients with gram-negative bacteremia
  177. Lingual tuberculosis in an HIV/AIDS patient
  178. Azole-resistant Aspergillus fumigatus harboring TR34/L98H, TR46/Y121F/T289A and TR53 mutations related to flower fields in Colombia
  179. Invasive Infections with Multidrug-Resistant Yeast Candida auris, Colombia
  180. Low–health literacy flashcards & mobile video reinforcement to improve medication adherence in patients on oral diabetes, heart failure, and hypertension medications
  181. International Nosocomial Infection Control Consortium report, data summary of 50 countries for 2010-2015: Device-associated module
  182. Identification of cryptic Candida species by MALDI-TOF mass spectrometry, not all MALDI-TOF systems are the same: focus on the C. parapsilosis species complex
  183. Risk factors for methicillin-resistant Staphylococcus aureus bacteremia: A multicenter matched case-control study
  184. Multicenter study in Colombia: Impact of a multidimensional International Nosocomial Infection Control Consortium (INICC) approach on central line–associated bloodstream infection rates
  185. Consenso colombiano para la estratificación, diagnóstico, tratamiento y prevención de la infección por citomegalovirus en pacientes adultos con trasplante renal
  186. Impact of an Analgesia-Based Sedation Protocol on Mechanically Ventilated Patients in a Medical Intensive Care Unit
  187. Saksenaea erythrospora infection after medical tourism for esthetic breast augmentation surgery
  188. Virus de hepatitis B y C. Retos en su tratamiento
  189. Pérdida de seguimiento y factores asociados en pacientes inscritos en el programa de HIV/sida del Hospital Universitario San Ignacio, Colombia, 2012-2013
  190. Characterization and Clinical Impact of Bloodstream Infection Caused by Carbapenemase-Producing Enterobacteriaceae in Seven Latin American Countries
  191. Abstract C59: Initiation of adjuvant hormonal therapy among uninsured stage I-III breast cancer patients treated in a safety-net healthcare system
  192. Factores de riesgo para bacteriemia adquirida en el hospital por Pseudomonas aeruginosa resistente a carbapenémicos en un hospital colombiano
  193. Challenges with Diagnosing and Managing Sepsis in Older Adults
  194. Tipranavir/Ritonavir (500/200 mg and 500/100 mg) Was Virologically Non-Inferior to Lopinavir/Ritonavir (400/100 mg) at Week 48 in Treatment-Naïve HIV-1-Infected Patients: A Randomized, Multinational, Multicenter Trial
  195. Multiple Fungicide-Driven Alterations in Azole-ResistantAspergillus fumigatus, Colombia, 2015
  196. Risk Factors Associated With Methicillin-Resistant Staphylococcus aureus (MRSA) Complicated Skin and Soft Tissue Infection in Colombia
  197. Guía de práctica clínica sobre diagnóstico y tratamiento de infección de vías urinarias no complicada en mujeres adquirida en la comunidad
  198. Safety Profile of Nifurtimox and Treatment Interruption for Chronic Chagas Disease in Colombian Adults
  199. Methicillin-Resistant Staphylococcus aureus USA300 Latin American Variant in Patients Undergoing Hemodialysis and HIV Infected in a Hospital in Bogotá, Colombia
  200. Exposure to High-Risk Medications is Associated With Worse Outcomes in Older Veterans With Chronic Pain
  201. Frecuencia de colonización de staphylococcus aureus meticilino - resistente, de enterobacterias y de candida spp. en estetoscopios y teléfonos móviles en una unidad de cuidados intensivos neonatal
  202. Cardiovascular Risk in Diabetes Mellitus: Complication of the Disease or of Antihyperglycemic Medications
  203. Sodium-glucose co-transporter inhibition in the treatment of diabetes: Sweetening the pot
  204. State-of-the-Art: Hypo-responsiveness to Oral Antiplatelet Therapy in Patients with Type 2 Diabetes Mellitus
  205. Association of skeletal muscle relaxers and antihistamines on mortality, hospitalizations, and emergency department visits in elderly patients: a nationwide retrospective cohort study
  206. Multicenter Study of Skin and Soft Tissue Infections Complicated in Hospitalized Patients 2009–2014 in Colombia
  207. Empiric Weight-Based Vancomycin in Intensive Care Unit Patients With Methicillin-Resistant Staphylococcus aureus Bacteremia
  208. Costo-efectividad de linezolid comparado con vancomicina en el manejo de la neumonía asociada a ventilación mecánica en Colombia
  209. Surgical site infection rates in 4 cities in Colombia: Findings of the International Nosocomial Infection Control Consortium (INICC)
  210. Azithromycin for Elderly Patients With Pneumonia—Reply
  211. Impact of empiric weight-based vancomycin dosing on nephrotoxicity and mortality in geriatric patients with methicillin-resistantStaphylococcus aureusbacteraemia
  212. International Nosocomial Infection Control Consortiu (INICC) report, data summary of 43 countries for 2007-2012. Device-associated module
  213. Gram-negative infections in pediatric and neonatal intensive care units of Latin America
  214. Efficacy of Three Different Regimens of Primaquine for the Prevention of Relapses of Plasmodium vivax Malaria in the Amazon Basin of Peru
  215. Extended spectrum β-lactamase producers among nosocomial Enterobacteriaceae in Latin America
  216. Association of Azithromycin With Mortality and Cardiovascular Events Among Older Patients Hospitalized With Pneumonia
  217. Primer consenso colombiano sobre Chagas congénito y orientación clínica a mujeres en edad fértil con diagnóstico de Chagas
  218. Impacto económico de la resistencia a meticilina en pacientes con bacteriemia por Staphylococcus aureus en hospitales de Bogotá
  219. Diseminación de Klebsiella pneumoniae productoras de KPC-3 en hospitales de Bogotá durante un periodo de tres años
  220. 155Implementation of a national surveillance program for antimicrobial use, Colombia 2012-2013
  221. Evolución de la resistencia antimicrobiana de bacilos Gram negativos en unidades de cuidados intensivos en Colombia
  222. Efecto del tratamiento antibiótico inicial adecuado sobre la mortalidad en pacientes en estado crítico con bacteriemia por Pseudomonas aeruginosa
  223. Molecular epidemiology and characterization of virulence genes of community-acquired and hospital-acquired methicillin-resistant Staphylococcus aureus isolates in Colombia
  224. Resistant Gram-negative infections in the outpatient setting in Latin America
  225. Surgical Site Infections, International Nosocomial Infection Control Consortium (INICC) Report, Data Summary of 30 Countries, 2005–2010
  226. The Quality of Quality Measures: HEDIS® Quality Measures for Medication Management in the Elderly and Outcomes Associated with New Exposure
  227. Emergencia de fenotipos resistentes a cefalosporinas de tercera generación en Enterobacteriaceae causantes de infección del tracto urinario de inicio comunitario en hospitales de Colombia
  228. Frequency of microorganisms isolated in patients with bacteremia in intensive care units in Colombia and their resistance profiles
  229. Predicting out of intensive care unit cardiopulmonary arrest or death using electronic medical record data
  230. Empiric guideline-recommended weight-based vancomycin dosing and nephrotoxicity rates in patients with methicillin-resistant Staphylococcus aureus bacteremia: a retrospective cohort study
  231. Consenso colombiano de neumonía nosocomial 2013
  232. Effectiveness of a multidimensional approach for prevention of ventilator-associated pneumonia in adult intensive care units from 14 developing countries of four continents
  233. Utilidad clínica de la detección antigénica de galactomanano en el diagnóstico de aspergilosis invasora en un hospital universitario de tercer nivel en Bogotá (Colombia) 2010–2012
  234. Mortality among critically ill patients with methicillin-resistant Staphylococcus aureus bacteremia: a multicenter cohort study in Colombia
  235. Sustained Efficacy and Safety of Raltegravir After 5 Years of Combination Antiretroviral Therapy as Initial Treatment of HIV-1 Infection
  236. Effectiveness of a multidimensional approach to reduce ventilator-associated pneumonia in pediatric intensive care units of 5 developing countries: International Nosocomial Infection Control Consortium findings
  237. Findings of the International Nosocomial Infection Control Consortium (INICC), Part II: Impact of a Multidimensional Strategy to Reduce Ventilator-Associated Pneumonia in Neonatal Intensive Care Units in 10 Developing Countries
  238. Findings of the International Nosocomial Infection Control Consortium (INICC), Part I: Effectiveness of a Multidimensional Infection Control Approach on Catheter-Associated Urinary Tract Infection Rates in Pediatric Intensive Care Units of 6 Developing...
  239. Impact of a multidimensional infection control strategy on catheter-associated urinary tract infection rates in the adult intensive care units of 15 developing countries: findings of the International Nosocomial Infection Control Consortium (INICC)
  240. International Nosocomial Infection Control Consortium (INICC) report, data summary of 36 countries, for 2004-2009
  241. Características demográficas, morbilidad y mortalidad de los pacientes adultos con neutropenia febril tratados con cefepima
  242. Effects of Oral Bisphosphonate Therapy on Serum Calcium in Elderly Veterans With Poor Kidney Function
  243. Empiric guideline-recommended weight-based vancomycin dosing and mortality in methicillin-resistant Staphylococcus aureus bacteremia: a retrospective cohort study
  244. Ranolazine for the treatment of refractory angina in a veterans population
  245. Uso prudente de antimicrobianos basado en el Plan Obligatorio de Salud
  246. The emergence of multidrug-resistant Acinetobacter baumannii in Colombia: a time-series analysis, 2001-2007
  247. Diagnóstico de micosis oportunistas en pacientes con VIH/sida: un estudio de casos en Colombia
  248. Consenso de uso de antimicrobianos en pacientes críticamente enfermos con falla renal o en riesgo de padecerla
  249. Bacteriemia por Staphylococcus aureus resistente a la meticilina en la unidad de cuidados intensivos: revisión de los estudios de pronóstico
  250. Detección de hipotiroidismo en un programa de atención de VIH/SIDA en un hospital de Bogotá, Colombia
  251. Impact of International Nosocomial Infection Control Consortium (INICC) Strategy on Central Line–Associated Bloodstream Infection Rates in the Intensive Care Units of 15 Developing Countries
  252. Guías de práctica clínica para la prevención de infecciones intrahospitalarias asociadas al uso de dispositivos médicos
  253. La prevención de las infecciones asociadas a la atención en salud: un reto en el mejoramiento de la seguridad del paciente
  254. Prevention strategies for methicillin-resistant Staphylococcus aureus (MRSA) in Latin America
  255. Evolution of methicillin-resistant Staphylococcus aureus clones in Latin America
  256. Resistencia bacteriana, transmisión cruzada y control de la infección asociada a la atención en salud
  257. Metabolic syndrome in HIV-infected patients receiving antiretroviral therapy in Latin America
  258. Nosocomial infections caused by community-associated methicillin-resistant Staphylococcus aureus in Colombia
  259. Metabolic syndrome in HIV-infected patients receiving antiretroviral therapy in Latin America
  260. Metabolic profile and cardiovascular risk factors among Latin American HIV-infected patients receiving HAART
  261. Differences in DeterminingIn VitroTigecycline Susceptibility According to the Agar Medium Used
  262. Central line associated bloodstream infection rates in 166 intensive care units of 54 cities in 23 developing countries: findings of the International Nosocomial Infection Control Consortium (INICC)
  263. Changes in macrophage membrane properties during early Leishmania amazonensis infection differ from those observed during established infection and are partially explained by phagocytosis
  264. Comparison between three not pharmacological strategies aimed to prevent the dissemination of the A/H1N1 influenza virus in Colombia
  265. Metabolic profile and cardiovascular risk factors among Latin American HIV-infected patients receiving HAART
  266. Switch to a raltegravir-based regimen versus continuation of a lopinavir-ritonavir-based regimen in stable HIV-infected patients with suppressed viraemia (SWITCHMRK 1 and 2): two multicentre, double-blind, randomised controlled trials
  267. Neumonía necrosante por Staphylococcus aureus extrahospitalario resistente a la meticilina:reporte de dos casos en Colombia
  268. Xantelasma gástrico sobre pólipo hiperplásico
  269. Epidemiology of meticillin-resistant Staphylococcus aureus (MRSA) in Latin America
  270. Transmisión de enfermedades en los vuelos comerciales: del mito a la realidad
  271. Comprometidos con el conocimiento y el control de las infecciones
  272. Combination thiazolidinedione and fibrate effect on high-density lipoprotein cholesterol (HDL-C) concentration in a Veterans Affairs patient population
  273. Validación de Índices Pronósticos e Infección del Sitio Quirúrgico en Hospitales de Colombia
  274. International Nosocomial Infection Control Consortium report, data summary for 2002-2007, issued January 2008
  275. Identification of Secreted Proteins that Mediate Cell-Cell Interactions in an In vitro Model of the Lung Cancer Microenvironment
  276. Third-Line Agent Selection for Patients with Type 2 Diabetes Mellitus Uncontrolled with Sulfonylureas and Metformin
  277. Haga usted el diagnóstico. Primera parte
  278. Haga usted el diagnóstico. Segunda parte
  279. Aerosolized nanostructured itraconazole as prophylaxis against invasive pulmonary aspergillosis
  280. Malaria in a Liver Transplant Recipient: A Case Report
  281. Device-Associated Nosocomial Infections in 55 Intensive Care Units of 8 Developing Countries
  282. Extra Length of Stay of Nosocomial Infections in Pediatric ICUs of Colombia and Mexico. Findings of the International Nosocomial Infection Control Consortium (INICC)
  283. Resistencia Antimicrobiana en Unidades de Cuidado Intensivo de Bogotá, Colombia, 2001-2003
  284. Canales Endémicos y Marcadores de Resistencia Bacteriana, en Instituciones de Tercer nivel de Bogota, Colombia
  285. Device-Associated Infection Rate and Mortality in Intensive Care Units of 9 Colombian Hospitals: Findings of the International Nosocomial Infection Control Consortium
  286. Community-associated Methicillin-resistantStaphylococcus aureus, Colombia
  287. AIDS in the Intensive Care Unit
  288. Application of natural gamma radiometric equipment in an underground mine in Spain
  289. Comparación de dos pruebas de aglutinación (Toxolatex ® y Toxoscreen ®) en el diagnóstico de la toxoplasmosis: propuesta de inclusión en un programa de control
  290. Prevalence of Trypanosoma cruzi and Leishmania chagasi infection and risk factors in a Colombian indigenous population
  291. Lagochilascaris minor IN A PATIENT FROM THE COLOMBIAN AMAZON: A CASE REPORT
  292. Current status of onchocerciasis in Colombia.
  293. Dissemination Control of the Antimicrobial Resistance in the Intensive Care Unit